Top Research Reports For 21st November, 2016

 | Nov 21, 2016 12:44AM ET

Monday, November 21 2016

Today's Research Daily features new research reports on 16 major stocks, including Coca-Cola (KO), Disney (DIS) and Danaher (NYSE:DHR).

Coca-Cola shares have struggled this year, with the stock down more than 4% in the year-to-date period compared to the roughly flat showing for the consumer staples sector as a whole. Driving the weakness has been headwinds from uncertain outlook for emerging markets, unfavorable currency movements and other structural issues like weakness in the company's North American sparkling beverage business. These issues notwithstanding, the company reported better-than-expected results in the third quarter of 2016 courtesy of higher prices for sodas and strong demand for water and sports drinks in North America. The analyst likes Coke’s formidable portfolio of globally recognized brands. The company has witnessed improved margins on higher pricing and smaller packaging in developed markets, amid slowing sales. (You can )

Disney shares have lagged its peers (the stock is down more than 6% year to date) on concerns about the impact of 'cord cutting' on the company's ESPN franchise. But Disney is more than just the ESPN franchise, as the analyst points out in the updated research report issued today. The analyst likes the company's movies business and favorable momentum in its parks and resorts division. The success of its movies also means greater business opportunities for its consumer products business. (You can )

Buy rated Danaher shares have struggled lately on concerns about its business repositioning that involved greater exposure to the healthcare and environmental verticlas following the Fortive spin-off. The analyst points out that the new Danaher is less exposed to volatile end-markets following the spin-off and has a more recurring revenue business. Two of the company’s latest acquisitions, namely Cepheid and Phenomenex, are expected to boost its already thriving Diagnostics and Life Sciences business, respectively. However, on the flip side, sluggish economic conditions across some key operating regions and unfavorable currency translations pose as significant headwinds. (You can )

Other noteworthy reports we are featuring today include Halliburton (NYSE:HAL), Teva (TEVA) and Time Warner (TWX).

Confidential: Best Trades from Zacks Research

Would you like to see a hand-picked "all-star" selection of investment ideas from the man who heads up Zacks' trading and investing services? Steve Reitmeister knows when key trades are about to be triggered and which of our experts has the hottest hand. He is now prepared to pass them along to you. Today Steve is also opening up Zacks' 7 Best Stocks for October, 2016 free of charge. From 220 Zacks Rank #1 Strong Buys, this Special tabs 7 for immediate breakout. Click to access these private picks>>

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Sheraz Mian

Director of Research

Note: If you want an email notification each time Sheraz publishes a new article, please

Today's Must Read/h6

Featured Reports/h6

The covering analyst thinks Time Warner's foray into new markets, strategic investments in video content and technology, and digital endeavors will help it continue with its upbeat performance.

The Zacks analyst highlights that headwinds remain in the form of generic competition for Copaxone.

The covering analyst believes that PG&E Corp's robust capital investments plans and continuous addition of customers to its portfolio will boost its future performance.

The Zacks analyst believes that PPL Corporation (NYSE:PPL)'s diverse asset portfolio and business model allow it to perform in and adapt to different market conditions.

The covering analyst believes that certain strategic initiatives that include cost reduction and the exercise of capital discipline resulted in BP's better-than-expected quarterly earnings.

The Zacks analyst thinks that cost and debt reduction actions will help it stay afloat amid a still weak copper pricing environment.

The covering analyst thinks the company's diligent cost cutting and restructuring initiatives are expected to offset weak client spending in automation business.

New Upgrades/h6

The Zacks analyst thinks Ross Stores reported a robust third-quarter fiscal 2016 backed by impressive dd's DISCOUNT performance as well as the improvement made in the ladies' apparel business.

Halliburton's effective cost management and improved utilization on the back of growing North American rig count has made the covering analyst turn bullish on the oilfield services behemoth.

The Zacks analyst believes the company will benefit from the new Gorilla Glass for automotive market, which will drive top-line growth in the long haul.

New Downgrades/h6

The Zacks analyst thinks earnings continue to be hampered by currency headwinds as evidenced in fiscal first quarter 2017. Management expects this trend to linger and impact results in fiscal 2017.

The covering analyst believes softness in commercial transport industry, weak defense aftermarket orders and waning business jet & freighter revenues remain major constraints for TransDigm's growth.

The Zacks analyst expects Bemis' fourth quarter to be affected by lower U.S packaging volumes and headwinds from its new healthcare packaging plant.

Zacks Investment Research

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes